Gelteq Ltd Logo

Gelteq Ltd

Ingestible gel platform for enhanced oral delivery of drugs & nutrients for human & animal health.

GELS | US

Overview

Corporate Details

ISIN(s):
AU0000218109
LEI:
Country:
United States of America
Address:
LEVEL 4, 3205 SOUTH MELBOURNE VIC
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Gelteq Ltd is a biotechnology company specializing in a proprietary, ingestible gel platform for the oral delivery of drugs and nutrients. Its patented technology converts existing orally delivered compounds into a customizable gel format designed to improve absorption, reduce choking risks, and address issues like dysphagia. A key feature of the platform is its stable matrix that can simultaneously integrate both water-soluble and lipid-soluble components. The company operates on a partnership model, providing white-label and tailored solutions for the pharmaceutical, nutraceutical, sports nutrition, and pet care industries, serving both human and animal markets. The technology was developed in collaboration with Monash University.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Gelteq Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Gelteq Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Gelteq Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
HLB INC. Logo
A diversified group in pharma, shipbuilding, life sciences, and professional advisory services.
South Korea 028300
HLB Life Science CO.,LTD. Logo
Develops anti-cancer drugs and distributes IVD medical devices and lab supplies internationally.
South Korea 067630
HLB PANAGENE Co., LTD. Logo
A global leader in PNA technology for cancer diagnostics and precision medicine.
South Korea 046210
HLB Pep Co., Ltd. Logo
Develops and produces GMP peptides, APIs, and custom synthesis for the biopharma industry.
South Korea 196300
HLB PHARMACEUTICAL CO., LTD. Logo
Researches cancer drugs and offers pharmaceutical CMO and manufacturing services.
South Korea 047920
HLB SCIENCE Inc. Logo
Develops innovative therapeutics and diagnostics for infectious and neurodegenerative diseases.
South Korea 343090
H. Lundbeck A Logo
Develops and commercializes innovative therapeutics for brain diseases globally.
Denmark HLUN
Hoth Therapeutics, Inc. Logo
Advancing therapeutics for metabolic, dermatologic, and inflammatory diseases.
United States of America HOTH
Global provider of medical aesthetic solutions like botulinum toxin and HA fillers.
South Korea 145020
Humacyte, Inc. Logo
Bioengineering off-the-shelf human tissues for vascular repair and regenerative medicine.
United States of America HUMA

Talk to a Data Expert

Have a question? We'll get back to you promptly.